Effects of chemotherapeutic agents for testicular cancer on rat spermatogonial stem/progenitor cells

Journal of Andrology

Volumn 32, Issue 4, 2011, Pages 432-443

  Marcon, Ludovic ^a   Zhang, Xiangfan ^a   Hales, Barbara F ^a   Robaire, Bernard ^a   Nagano, Makoto C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Bleomycin; Chemotherapy; Cisplatin; Enhanced green fluorescent protein; Etoposide; Gfra1; Spermatogenesis; Transgenic rats; Undifferentiated type A spermatogonia; Zbtb16

Indexed keywords

BIOLOGICAL MARKER; BLEOMYCIN; CISPLATIN; ETOPOSIDE; PROTEIN GFRA1; PROTEIN ZBTB16; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; GERM LINE; IMMUNOFLUORESCENCE TEST; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPRODUCTIVE TOXICITY; SEMINIFEROUS TUBULE; SPERMATOGENESIS; SPERMATOGONIAL STEM CELL; SPERMATOGONIUM; STEM CELL; STEM CELL TRANSPLANTATION; TESTIS CANCER; TESTIS WEIGHT; ANIMAL; SPERMATOZOON; TESTIS TUMOR; TRANSGENIC RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; ETOPOSIDE; MALE; RATS; RATS, TRANSGENIC; SEMINIFEROUS TUBULES; SPERMATOGONIA; SPERMATOZOA; STEM CELLS; TESTICULAR NEOPLASMS;

EID: 80052675631     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.110.011601     Document Type: Article

References (45)

1. Aguilar-Mahecha A, Hales BF, Robaire B. Expression of stress response genes in germ cells during spermatogenesis. Biol Reprod. 2001;65:119-127.
2. Arai Y, Kawakita M, Okada Y, Yoshida O. Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol. 1997;15: 1444-1448.
3. Bellvé AR, Millette CF, Bhatnagar YM, O'Brien DA. Dissociation of the mouse testis and characterization of isolated spermatogenic cells. J Histochem Cytochem. 1977;25:480-494.
4. Bieber AM, Marcon L, Hales BF, Robaire B. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility. J Androl. 2006;27:189-200.
5. Brinster RL. Germline stem cell transplantation and transgenesis. Science. 2002;296:2174-2176.
6. Buaas FW, Kirsh AL, Sharma M, McLean DJ, Morris JL, Griswold MD, de Rooij DG, Braun RE. Plzf is required in adult male germ cells for stem cell self-renewal. Nat Genet. 2004;36:647-652.
7. Chaudhary UB, Haldas JR. Long-term complications of chemotherapy for germ cell tumours. Drugs. 2003;63:1565-1577.
8. Cherry SM, Hunt PA, Hassold TJ. Cisplatin disrupts mammalian spermatogenesis, but does not affect recombination or chromosome segregation. Mutat Res. 2004;564:115-128.
9. Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M, Orwig KE, Wolgemuth DJ, Pandolfi PP. Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet. 2004;36:653-659.
10. Cronkhite JT, Norlander C, Furth JK, Levan G, Garbers DL, Hammer RE. Male and female germline specific expression of an EGFP reporter gene in a unique strain of transgenic rats. Dev Biol. 2005;284:171-183.
11. De Rooij DG. Proliferation and differentiation of spermatogonial stem cells. Reproduction. 2001;121:347-354.
12. Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ. Medical treatment of advanced testicular cancer. JAMA. 2008;299:672-684.
13. Fouchécourt S, Godet M, Sabido O, Durand P. Glial cell-line-derived neurotropic factor and its receptors are expressed by germinal and somatic cells of the rat testis. J Endocrinol. 2006;190:59-71.
14. Grisanti L, Falciatori I, Grasso M, Dovere L, Fera S, Muciaccia B, Fuso A, Berno V, Boitani C, Stefanini M, Vicini E. Identification of spermatogonial stem cell subsets by morphological analysis and prospective isolation. Stem Cells. 2009;27:3043-3052.
15. Hamer G, Roepers-Gajadien HL, Gademan IS, Kal HB, De Rooij DG. Intercellular bridges and apoptosis in clones of male germ cells. Int J Androl. 2003;26(6):348-353.
16. Hartmann JT, Albrecht C, Schmoll HJ, Kuczyk MA, Kollmannsberger C, Bokemeyer C. Long-term effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer. 1999;80:801-807.
17. Hermann BP, Sukhwani M, Lin CC, Sheng Y, Tomko J, Rodriguez M, Shuttleworth JJ, McFarland D, Hobbs RM, Pandolfi PP, Schatten GP, Orwig KE. Characterization, cryopreservation, and ablation of spermatogonial stem cells in adult rhesus macaques. Stem Cells. 2007;25:2330-2338.
18. Hermann BP, Sukhwani M, Simorangkir DR, Chu T, Plant TM, Orwig KE. Molecular dissection of the male germ cell lineage identifies putative spermatogonial stem cells in rhesus macaques. Hum Reprod. 2009;24:1704-1716.
19. Hofmann MC, Braydich-Stolle L, Dym M. Isolation of male germ-line stem cells; influence of GDNF. Dev Biol. 2005;279:114-124.
20. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12-17.
21. Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E, Dearnaley DP. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer. 2005;93:200-207.
22. Kadota T, Chikazawa H, Takahashi N. Toxicological study of etoposide (VP-16) in rats with special emphasis on testicular alteration. Toxicol Lett. 1989;45:185-194.
23. Kanatsu-Shinohara M, Toyokuni S, Morimoto T, Matsui S, Honjo T, Shinohara T. Functional assessment of self-renewal activity of male germline stem cells following cytotoxic damage and serial transplantation. Biol Reprod. 2003;68:1801-1807.
24. Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol. 1997;15:239-245.
25. Malkov M, Fisher Y, Don J. Developmental schedule of the postnatal rat testis determined by flow cytometry. Biol Reprod. 1998;59:84-92.
26. Marcon L, Hales BF, Robaire B. Reversibility of the effects of subchronic exposure to the cancer chemotherapeutics bleomycin, etoposide, and cisplatin on spermatogenesis, fertility, and progeny outcome in the male rat. J Androl. 2008;29:408-417.
27. Marcon L, Zhang X, Hales BF, Nagano MC, Robaire B. Development of a short-term fluorescence-based assay to assess the toxicity of anticancer drugs on rat stem/progenitor spermatogonia in vitro. Biol Reprod. 2010;83:228-237.
28. Meistrich ML. Relationship between spermatogonial stem cell survival and testis function after cytotoxic therapy. Br J Cancer Suppl. 1986;7:89-101.
29. Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis. Eur Urol. 1993;23:136-141.
30. Meistrich ML, Finch M, da Cunha MF, Hacker U, Au WW. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res. 1982;42:122-131.
31. Nakagawa T, Sharma M, Nabeshima Y, Braun RE, Yoshida S. Functional hierarchy and reversibility within the murine spermatogenic stem cell compartment. Science. 2010;328:62-67.
32. Nagano M, Avarbock MR, Brinster RL. Pattern and kinetics of mouse donor spermatogonial stem cell colonization in recipient testes. Biol Reprod. 1999;60:1429-1436.
33. Oatley JM, Brinster RL. Spermatogonial stem cells. Methods Enzymol. 2006;419:259-282.
34. Oatley JM, Brinster RL. Regulation of spermatogonial stem cell selfrenewal in mammals. Annu Rev Cell Dev Biol. 2008;24:263-286.
35. Petersen PM, Hansen SW, Giwercman A, Rørth M, Skakkebaek NE. Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol. 1994;5:355-358.
36. Ryu BY, Kubota H, Avarbock MR, Brinster RL. Conservation of spermatogonial stem cell self-renewal signaling between mouse and rat. Proc Natl Acad Sci U S A. 2005;102:14302-14307.
37. Sabanegh ES Jr, Ragheb AM. Male fertility after cancer. Urology. 2009;73:225-231.
38. Sada A, Suzuki A, Suzuki H, Saga Y. The RNA-binding protein NANOS2 is required to maintain murine spermatogonial stem cells. Science. 2009;325:1394-1398.
39. Sawhney P, Giammona CJ, Meistrich ML, Richburg JH. Cisplatininduced long-term failure of spermatogenesis in adult C57/Bl/6J mice. J Androl. 2005;26:136-145.
40. Shuttlesworth GA, de Rooij DG, Huhtaniemi I, Reissmann T, Russell LD, Shetty G, Wilson G, Meistrich ML. Enhancement of A spermatogonial proliferation and differentiation in irradiated rats by gonadotropin-releasing hormone antagonist administration. Endocrinology. 2000;141(1):37-49.
41. Suzuki H, Sada A, Yoshida S, Saga Y. The heterogeneity of spermatogonia is revealed by their topology and expression of marker proteins including the germ cell-specific proteins Nanos2 and Nanos3. Dev Biol. 2009;336:222-231.
42. Tokuda M, Kadokawa Y, Kurahashi H, Marunouchi T. CDH1 is a specific marker for undifferentiated spermatogonia in mouse testes. Biol Reprod. 2007;76:130-141.
43. Trasler JM, Hales BF, Robaire B. A time-course study of chronic paternal cyclophophosphamide treatment in rats: effects on pregnancy outcome and the male reproductive and hematologic systems. Biol Reprod. 1987;37:317-326.
44. van Bragt MP, Roepers-Gajadien HL, Korver CM, Bogerd J, Okuda A, Eggen BJ, de Rooij DG, van Pelt AM. Expression of the pluripotency marker UTF1 is restricted to a subpopulation of early A spermatogonia in rat testis. Reproduction. 2008;136:33-40.
45. Yoshida S, Sukeno M, Nabeshima Y. A vasculature-associated niche for undifferentiated spermatogonia in the mouse testis. Science. 2007;317:1722-1726.